| Innovation Title | Categories | Lead Inventor | |
|---|---|---|---|
|
New Target Identified for Cancer Therapy and Its Inhibitor
2018-DAI-68268 |
Dai, Mingji | ||
|
Antimicrobial Compounds Show Promise for Treating Drug-Resistant Bacterial Infections
2017-DAI-67938 |
|
Dai, Mingji | |
|
Compounds with Promising Antibacterial and Antifungal Activity for New Therapeutic Development
2017-DAI-67879 |
Dai, Mingji | ||
|
Novel Aryl Isonitrile Antimicrobials Active Against Clinically Important Bacterial Strains
2015-DAI-67104 |
Dai, Mingji | ||
|
Neuropathic and Inflammatory Pain Therapeutics Targeting Adenylyl Cyclase
2015-DAI-67035 |
Dai, Mingji | ||
|
Novel Imaging to Study Cell Functions
2014-CHEN-66885 |
Cheng, Ji-xin | ||
|
Dr. Mingji Dai is an Associate Professor of Organic Chemistry at Purdue University. Dr. Dai earned his B.S. from Peking University, his Ph.D. from Columbia University (dissertation awarded with distinction), and was a Postdoctoral Fellow at Harvard University and the Broad Institute. In 2016, Dr. Dai received the NSF CAREER Award. He is also the recipient of the 2015 Organic Letters Outstanding Author of the Year Lectureship Award, the Eli Lilly Grantee Award, and the Amgen Young Investigator Award. His research program works with both natural and unnatural molecules with particular potential for the treatment of cancer, CNS disorders, and infectious diseases. Dr. Dai also focuses on creating unconventional and diverse small molecule collections to target protein-protein interactions and exploring reversible and irreversible covalent small molecule protein interactions and their application in biology and drug discovery. For additional information, visit Dr. Dai's Purdue website: https://www.chem.purdue.edu/people/directory/faculty/details/95 or the Dai Research Group website: http://www.chem.purdue.edu/dai |
|
|